A controversial new drug for Alzheimer’s
1 big thing8 Kesä 2021

A controversial new drug for Alzheimer’s

The FDA has approved a new Alzheimer’s drug for the first time in almost 20 years. The hope is it would treat the more than 6 million Americans living with Alzheimer’s disease. But the effectiveness of the drug is up for question. Plus, the Biden administration’s split stance on Puerto Ricans and benefits. And, the upside to online concerts. Guests: Jose Delgado, Washington correspondent of El Nuevo Dia and Axios' Bob Herman, and Erica Pandey. Credits: Axios Today is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Sara Kehaulani Goo, Dan Bobkoff, Alexandra Botti, Nuria Marquez Martinez, Sabeena Singhani, and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. Go deeper: FDA approves Biogen's Alzheimer's drug despite lack of evidence The future of concerts is hybrid

Jaksot(881)

Mixed messaging on masks

Mixed messaging on masks

This week, a number of democratic governors announced that their states are dropping their mask mandates and ending some COVID restrictions. And at the same time, CDC guidance continues to recommend i...

10 Helmi 202211min

The "Don’t Say Gay" bill gains momentum in Florida

The "Don’t Say Gay" bill gains momentum in Florida

This week, Florida Governor Ron DeSantis expressed his support for what critics are calling the “Don't Say Gay” bill. It could restrict LGBTQ discussion in elementary schools and allow parents to sue ...

9 Helmi 202211min

Fixing the healthcare worker shortage

Fixing the healthcare worker shortage

Nearly one in five health care workers quit their jobs since the start of the pandemic according to a poll in recent months by Morning Consult. So what’s being done to keep health care workers on the ...

8 Helmi 202211min

The influencers dominating the GOP

The influencers dominating the GOP

Power within the Republican party changed with lightening speed over the past several years. Axios' Jonathan Swan spoke with more than a dozen top GOP consultants - from the Trumpians to the most inst...

7 Helmi 202211min

The tenuous balance of power in the Senate

The tenuous balance of power in the Senate

Democrats are down a crucial vote in the Senate after New Mexico Sen. Ben Ray Luján suffered a stroke. While the 49-year old senator is expected to make a full recovery, his absence means a shift in t...

4 Helmi 202211min

Omicron’s negative impact on American jobs

Omicron’s negative impact on American jobs

In January, nearly 9 million people missed work because they were sick with COVID or taking care of someone. That's why many, including President Biden, are bracing for disappointing January job numbe...

3 Helmi 202210min

Reality check on the Russia-Ukraine crisis

Reality check on the Russia-Ukraine crisis

Russian President Vladimir Putin said yesterday that the U.S. was trying to pull Russia into a conflict it does not want with Ukraine. Meanwhile, we’ve heard mixed messages from the Ukraine government...

2 Helmi 202211min

The rise in fertility benefits for employees

The rise in fertility benefits for employees

In this tight labor market, more companies are trying to lure and keep employees by providing fertility benefits like egg freezing or in vitro fertilization. Plus, China’s "closed loop" system for th...

1 Helmi 202211min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
politiikan-puskaradio
tervo-halme
rss-podme-livebox
rss-vaalirankkurit-podcast
et-sa-noin-voi-sanoo-esittaa
the-ulkopolitist
otetaan-yhdet
rss-asiastudio
aihe
rikosmyytit
rss-hyvaa-huomenta-bryssel
rss-merja-mahkan-rahat
rss-kaikki-uusiksi
rss-aijat-hopottaa-podcast
rss-raha-talous-ja-politiikka
viisupodi